发明申请
US20050244463A1 Sustained release intraocular implants and methods for treating ocular vasculopathies
审中-公开
持续释放眼内植入物和治疗眼血管病变的方法
- 专利标题: Sustained release intraocular implants and methods for treating ocular vasculopathies
- 专利标题(中): 持续释放眼内植入物和治疗眼血管病变的方法
-
申请号: US10836911申请日: 2004-04-30
-
公开(公告)号: US20050244463A1公开(公告)日: 2005-11-03
- 发明人: Glenn Huang , Brittany Jackson , James Burke , Ton Lin , Patrick Hughes , Larry Wheeler , Rosy Donn
- 申请人: Glenn Huang , Brittany Jackson , James Burke , Ton Lin , Patrick Hughes , Larry Wheeler , Rosy Donn
- 申请人地址: US CA Irvine
- 专利权人: Allergan, Inc.
- 当前专利权人: Allergan, Inc.
- 当前专利权人地址: US CA Irvine
- 主分类号: A61K9/00
- IPC分类号: A61K9/00 ; A61K31/498
摘要:
Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, among others.